Literature DB >> 20446110

Counselling behaviour and content in a pharmaceutical care service in Swedish community pharmacies.

Anna T Montgomery1, Asa Kettis Lindblad, Pernilla Eddby, Emelie Söderlund, Mary P Tully, Sofia Kälvemark Sporrong.   

Abstract

OBJECTIVE: To characterise the counselling behaviour of practitioners providing a pharmaceutical care (PC) service in community pharmacy, and to describe the content of the consultations.
SETTING: Community pharmacies in Sweden.
METHODS: Non-participant observations, including audio recording, of five practitioners in five different pharmacies counselling 16 patients, were analysed qualitatively using an iterative, stepwise, interpretivist approach. MAIN OUTCOME MEASURE: Descriptions of counselling behaviour and content of consultations.
RESULTS: The counselling behaviour was characterised by attempts to understand the patients' narratives by listening and asking questions and a willingness to help. The computer often had an important role in consultations, being used for documentation and as a supportive tool for identification of drug-drug interactions. The practitioners often took command in the initial phase of the consultation, and omitted to determine the patients' most urgent drug-related needs. However, counselling behaviour that identified and focused on the patient's needs, giving the computer little attention during the consultation was also observed. Practitioners provided vague descriptions of the purpose and outline of the service. Consultations included a wide variety of issues, which potentially could help patients' achieve optimal outcomes of medical treatment.
CONCLUSION: The practitioners provided important advice and different forms of support to patients. Focus on the computer screen limited their abilities to practise patient centred care.

Entities:  

Mesh:

Year:  2010        PMID: 20446110     DOI: 10.1007/s11096-010-9391-z

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  24 in total

1.  Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment.

Authors:  D C Bultman; B L Svarstad
Journal:  Patient Educ Couns       Date:  2000-05

2.  Construct identification and measure development for investigating pharmacist-patient relationships.

Authors:  Marcia M Worley-Louis; Jon C Schommer; John R Finnegan
Journal:  Patient Educ Couns       Date:  2003-11

3.  Community pharmacy-based pharmaceutical care for asthma patients.

Authors:  Sandra Mangiapane; Martin Schulz; Stephan Mühlig; Peter Ihle; Ingrid Schubert; Hans-Christian Waldmann
Journal:  Ann Pharmacother       Date:  2005-10-11       Impact factor: 3.154

4.  Receiving a pharmaceutical care service compared to receiving standard pharmacy service in Sweden--How do patients differ with regard to perceptions of medicine use and the pharmacy encounter?

Authors:  Anna T Montgomery; Sofia Kälvemark Sporrong; Nila Manap; Mary P Tully; Asa Kettis Lindblad
Journal:  Res Social Adm Pharm       Date:  2009-11-06

5.  Improving drug therapy for patients with asthma--part 1: Patient outcomes.

Authors:  H Herborg; B Soendergaard; B Froekjaer; L Fonnesbaek; T Jorgensen; C D Hepler; T J Grainger-Rousseau; B K Ersboell
Journal:  J Am Pharm Assoc (Wash)       Date:  2001 Jul-Aug

6.  Pharmacists' and patients' roles in the pharmacist-patient relationship: are pharmacists and patients reading from the same relationship script?

Authors:  Marcia M Worley; Jon C Schommer; Lawrence M Brown; Ronald S Hadsall; Paul L Ranelli; Timothy P Stratton; Donald L Uden
Journal:  Res Social Adm Pharm       Date:  2007-03

7.  The patient-centredness of consultations and outcome in primary care.

Authors:  P Kinnersley; N Stott; T J Peters; I Harvey
Journal:  Br J Gen Pract       Date:  1999-09       Impact factor: 5.386

8.  Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy.

Authors:  Dara C Bultman; Bonnie L Svarstad
Journal:  J Am Pharm Assoc (Wash)       Date:  2002 Jan-Feb

9.  Qualitative research: Observational methods in health care settings.

Authors:  N Mays; C Pope
Journal:  BMJ       Date:  1995-07-15

10.  The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia.

Authors:  I Krass; C L Armour; B Mitchell; M Brillant; R Dienaar; J Hughes; P Lau; G Peterson; K Stewart; S Taylor; J Wilkinson
Journal:  Diabet Med       Date:  2007-06       Impact factor: 4.359

View more
  6 in total

1.  Indigenous and immigrant populations' use and experience of community pharmacies in New Zealand.

Authors:  James A Green; Kasey Brown; Jason Burgess; Doris Chong; Kevin Pewhairangi
Journal:  J Immigr Minor Health       Date:  2013-02

2.  A conceptual framework of patient satisfaction with a pharmacy adherence service.

Authors:  Melandi van den Berg; Parastou Donyai
Journal:  Int J Clin Pharm       Date:  2013-12-05

3.  Contribution of Slovenian community pharmacist counseling to patients' knowledge about their prescription medicines: a cross-sectional study.

Authors:  Nejc Horvat; Mitja Kos
Journal:  Croat Med J       Date:  2015-02       Impact factor: 1.351

4.  Pharmacist's recommendations of over-the-counter treatments for the common cold - analysis of prospective cases in Poland.

Authors:  Malgorzata Pietrusiewicz; Paulina Natalia Kopa-Stojak; Rafal Pawliczak
Journal:  BMC Fam Pract       Date:  2021-10-30       Impact factor: 2.497

Review 5.  Exploring the concept of patient centred communication for the pharmacy practice.

Authors:  Majanne Wolters; Rolf van Hulten; Lyda Blom; Marcel L Bouvy
Journal:  Int J Clin Pharm       Date:  2017-09-09

6.  Determining counselling communication strategies associated with successful quits in the National Health Service community pharmacy Stop Smoking programme in East London: a focused ethnography using recorded consultations.

Authors:  Carol Rivas; Ratna Sohanpal; Virginia MacNeill; Liz Steed; Elizabeth Edwards; Laurence Antao; Chris Griffiths; Sandra Eldridge; Stephanie Taylor; Robert Walton
Journal:  BMJ Open       Date:  2017-10-27       Impact factor: 2.692

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.